Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2015

Aug 5, 2015

29841_dirs_2015-08-05_2dfa8663-d0f1-4cf5-a896-ee272b9acb7f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2015-08-03

Reporting Person: Ellis Gary Lee (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-08-03 Ordinary Shares A 18697 Acquired 174021 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-08-03 Employee Stock Option (right to buy) $78 A 74787 Acquired 2025-08-03 Ordinary Shares (74787) Direct
2015-08-03 Employee Stock Option (right to buy) $78 A 1283 Acquired 2025-08-03 Ordinary Shares (1283) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 5137 Indirect
Ordinary Shares 7699 Indirect

Footnotes

F1: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2018 equals or exceeds a 3% compound annual growth rate, as determined by the Compensation Committee.

F2: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.